Matthew Ros, Chief Operating Officer at Epizyme, Inc. (EPZM), sold 143,490 shares at $16.63 ($2.4M) on 2018-02-05, disclosed to the SEC on 2018-02-06.
Open-market sale of $2.4M EPZM by Chief Operating Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.63 | 71,745 | $1.2M | 50.0% |
| 2 | $16.63 | 71,745 | $1.2M | 50.0% |
| Total | $16.63 avg | 143,490 | $2.4M | 100% |
| Filing → |
| EPZM | SELL | 2020-06-30 | $44K | — | Filing → |
| EPZM | SELL | 2020-06-22 | $4.7M | — | Filing → |
| EPZM | SELL | 2020-03-26 | $19K | — | Filing → |